News
StockStory.org on MSN9d
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings?What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many ...
Headquartered in Mountain View, CA, Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply ...
Dr. Genova will lead Omnicell’s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings Medical device ...
Omnicell OMCL underwent analysis by 4 analysts ... The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses ...
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...
4mon
Zacks.com on MSNOmnicell Introduces OmniSphere Platform, Stock to GainOmnicell, Inc. OMCL recently introduced OmniSphere, a next-generation, cloud-native software workflow engine and data ...
Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat reports. Four equities ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results